based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Thyrocare Technologies Ltd. An average target of ₹980
Source: S&P Global Market Intelligence
Thyrocare Technologies Ltd price forecast by 2 analysts
Upside of24.56%
High
₹1050
Target
₹980.00
Low
₹910
Thyrocare Technologies Ltd target price ₹980, a slight upside of 24.56% compared to current price of ₹775.9. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Thyrocare Technologies Ltd revenue growth forecast
Expected growth rate Q1, FY2027:64.55%
Forecast
Actual
Including amortisation and stock based compensations
Thyrocare Technologies Ltd EPS growth forecast
EPS estimate Q1, FY2027:118.56%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -13.22 % |
3 Month Return | -17.14 % |
1 Year Return | + 27.36 % |
Market Stats | |
Previous Close | ₹786.75 |
Open | ₹775.90 |
Volume | 72.89K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,169.13Cr |
P/E Ratio | 47.31 |
PEG Ratio | 10.78 |
Market Cap | ₹4,169.13 Cr |
P/B Ratio | 6.54 |
EPS | 13.12 |
Dividend Yield | 3.04 |
Sector | Healthcare |
ROE | 13.75 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,169.13 Cr | 7.76% | 0.54 | ₹69 Cr | ₹571 Cr | |
BUY | ₹10,026.39 Cr | 11.51% | 0.64 | ₹119 Cr | ₹547 Cr | |
HOLD | ₹9,184.29 Cr | 1.66% | 0.58 | ₹128 Cr | ₹1,207 Cr | |
HOLD | ₹23,061.86 Cr | 12.06% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
HOLD | ₹29,319.48 Cr | 104.82% | 0.67 | ₹168 Cr | ₹5,040 Cr |
Organisation | Thyrocare Technologies Ltd |
Headquarters | Navi Mumbai |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Thyrocare Technologies Ltd
Thyrocare Reports Strong Earnings Amid Stock Concerns - 23 Jan, 2025
Thyrocare Technologies Reports Mixed Performance - 07 Jan, 2025
Thyrocare Technologies Achieves Strong Performance and Upgrades - 06 Jan, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 1.93% to 2.77% in Dec 2024 quarter
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 179.0% return, outperforming this stock by 198.0%
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 49.7% return, outperforming this stock by 22.3%
Price Dip
In the last 3 years, THYROCARE stock has moved down by -19.0%
Retail Holding Down
Retail Investor have decreased holdings from 12.16% to 11.49% in Dec 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 71.11% to 71.06% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 12.90% to 12.75% in Dec 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 26.67 Cr → 19.11 Cr (in ₹), with an average decrease of 28.4% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 179.97 Cr → 169.93 Cr (in ₹), with an average decrease of 5.6% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 71.06% | ||
Foreign Institutions | 2.77% | 43.97 | |
Mutual Funds | 12.75% | ||
Retail Investors | 11.49% | ||
Others | 1.93% | 1.70 |
Thyrocare Technologies Ltd in the last 5 years
Lowest (18.71x)
June 23, 2022
Today (47.31x)
January 29, 2025
Industry (92.84x)
January 29, 2025
Highest (91.79x)
October 27, 2020
Thyrocare Technologies Ltd’s net profit jumped 24.5% since last year same period to ₹19.11Cr in the Q3 2024-2025. On a quarterly growth basis, Thyrocare Technologies Ltd has generated -28.35% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Thyrocare Technologies Ltd has declared dividend of ₹18 - translating a dividend yield of 2.29%.
Read More about DividendsBearish
Neutral
Bullish
Thyrocare Technologies Ltd is currently in a Bearish trading position according to technical analysis indicators.
Thyrocare Technologies Ltd share price today stands at ₹775.9, Open: ₹775.9, Previous Close: ₹786.75, High: ₹788.55, Low: ₹770.15, 52 Week High: ₹1055, 52 Week Low: ₹554.1.
Thyrocare Technologies Ltd is listed on NSE
Thyrocare Technologies Ltd is listed on BSE
Today's traded volume of Thyrocare Technologies Ltd(THYROCARE) is 72.89K.
Today's market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹4169.13Cr.
Thyrocare Technologies Ltd (THYROCARE) share price is ₹775.9. It is down -26.45% from its 52 Week High price of ₹1055
Thyrocare Technologies Ltd (THYROCARE) share price is ₹775.9. It is up 40.03% from its 52 Week Low price of ₹554.1
PE Ratio of Thyrocare Technologies Ltd is 47.31
PE ratio = Thyrocare Technologies Ltd Market price per share / Thyrocare Technologies Ltd Earnings per share